BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
DRD2
,
Response to oxidative stress
,
Allergy to pollen
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
evidence of thrombotic microangiopathy
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for evidence of thrombotic microangiopathy
Explore Curated Studies Results
Literature
Most Relevant Literature
ANCA negative pulmonary renal syndrome with pathologic findings of thrombotic microangiopathy.
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent th…
Pathophysiology of thrombotic thrombocytopenic purpura.
Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.
Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ